Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Target-enabling packages provide a crucial link between human genetics and disease biology to accelerate drug discovery in cancer and malaria

The SGC has released its first set of Target-Enabling Packages (TEPs) to the scientific community.

There is a growing gap between the number of proteins that have been genetically linked to human disease and researchers’ ability to both study the proteins and to understand how the proteins relate to the disease. To address this gap, the SGC is generating and releasing data, assay and informational packages called TEPs to the scientific community.

 

Read more ...